Compounds > bosentan anhydrous
Page last updated: 2024-08-26

bosentan anhydrous and Scleroderma, Diffuse

bosentan anhydrous has been researched along with Scleroderma, Diffuse in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Champion, HC; Girgis, RE; Hassoun, PM; Hummers, LK; Mathai, SC; Wigley, FM; Zaiman, A1
Ambach, A; Bonnekoh, B; Gollnick, H; Seo, W1
Asano, Y; Hatano, M; Ichimura, Y; Kawashima, T; Kinugawa, K; Kogure, A; Mitsui, H; Miyazaki, M; Sato, S; Sugaya, M; Takahashi, T; Takekoshi, T; Tamaki, Z; Taniguchi, T; Tomita, M; Yao, A1

Other Studies

3 other study(ies) available for bosentan anhydrous and Scleroderma, Diffuse

ArticleYear
Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.
    Arthritis and rheumatism, 2009, Volume: 60, Issue:2

    Topics: Bosentan; Cohort Studies; Comorbidity; Endothelin Receptor Antagonists; Female; Follow-Up Studies; Humans; Hypertension, Pulmonary; Isoxazoles; Lung Diseases, Interstitial; Male; Maryland; Middle Aged; Piperazines; Prognosis; Proportional Hazards Models; Purines; Receptors, Endothelin; Scleroderma, Diffuse; Scleroderma, Systemic; Sildenafil Citrate; Sulfonamides; Sulfones; Survival Rate; Thiophenes; Vasodilator Agents

2009
Low-dose combination therapy of severe digital ulcers in diffuse progressive systemic sclerosis with the endothelin-1 receptor antagonist bosentan and the phosphodiesterase V inhibitor sildenafil.
    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2009, Volume: 7, Issue:10

    Topics: Aged; Bosentan; Drug Therapy, Combination; Endothelin Receptor Antagonists; Female; Fingers; Hand Dermatoses; Humans; Phosphodiesterase Inhibitors; Piperazines; Purines; Scleroderma, Diffuse; Sildenafil Citrate; Sulfonamides; Sulfones; Treatment Outcome; Ulcer

2009
Significant attenuation of macrovascular involvement by bosentan in a patient with diffuse cutaneous systemic sclerosis with multiple digital ulcers and gangrene.
    Modern rheumatology, 2011, Volume: 21, Issue:5

    Topics: Antihypertensive Agents; Bosentan; Female; Fingers; Gangrene; Humans; Middle Aged; Regional Blood Flow; Scleroderma, Diffuse; Skin Ulcer; Sulfonamides

2011